Identification and characterization of cholesterol esterase and lipase inhibitory peptides from amaranth protein hydrolysates
Human diet is undergoing a shift towards plant-based diet as a sustainable source of protein compared to animal-derived protein. In this study, cholesterol esterase (CEase) and pancreatic lipase (PL) inhibitory activities of amaranth protein hydrolysates (APHs) were studied. Bromelain, chymotrypsin,...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e41ee6f5000b4ef8acc32306231a590f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e41ee6f5000b4ef8acc32306231a590f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e41ee6f5000b4ef8acc32306231a590f2021-11-28T04:37:50ZIdentification and characterization of cholesterol esterase and lipase inhibitory peptides from amaranth protein hydrolysates2590-157510.1016/j.fochx.2021.100165https://doaj.org/article/e41ee6f5000b4ef8acc32306231a590f2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2590157521000535https://doaj.org/toc/2590-1575Human diet is undergoing a shift towards plant-based diet as a sustainable source of protein compared to animal-derived protein. In this study, cholesterol esterase (CEase) and pancreatic lipase (PL) inhibitory activities of amaranth protein hydrolysates (APHs) were studied. Bromelain, chymotrypsin, and actinase E were used for generating APHs at 2, 4 & 6 h of hydrolysis. Higher PL inhibiting potential were observed in bromelain-derived APHs (IC50 = 0.38–0.66 mg/mL) in comparison to intact amaranth proteins (IC50 = 3.93 mg/mL). Bromelain-4 h hydrolysates (AB4) demonstrated significant inhibitory potential for both CEase (IC50 = 0.47 mg/mL) and PL (IC50 = 0.48 mg/mL) activity. Peptide identification in AB-4 hydrolysate revealed that among 17 bioactive peptides, three peptides (FPFPPTLGY, FGAPR, and FPFVPAPT) were predicted as potential PL inhibitors and only one peptide (FPFVPAPT) was predicted as CEase inhibitor based on the number of substrate binding sites on active site of the enzymes. This is the first study providing insights into amaranth protein derived bioactive peptide possessing CEase and LIP inhibitory potential.Feyisola Fisayo AjayiPriti MudgilChee-Yuen GanSajid MaqsoodElsevierarticleAmaranth hydrolysatesBioactive peptidesPancreatic lipaseCholesterol esteraseHPLCNutrition. Foods and food supplyTX341-641Food processing and manufactureTP368-456ENFood Chemistry: X, Vol 12, Iss , Pp 100165- (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Amaranth hydrolysates Bioactive peptides Pancreatic lipase Cholesterol esterase HPLC Nutrition. Foods and food supply TX341-641 Food processing and manufacture TP368-456 |
spellingShingle |
Amaranth hydrolysates Bioactive peptides Pancreatic lipase Cholesterol esterase HPLC Nutrition. Foods and food supply TX341-641 Food processing and manufacture TP368-456 Feyisola Fisayo Ajayi Priti Mudgil Chee-Yuen Gan Sajid Maqsood Identification and characterization of cholesterol esterase and lipase inhibitory peptides from amaranth protein hydrolysates |
description |
Human diet is undergoing a shift towards plant-based diet as a sustainable source of protein compared to animal-derived protein. In this study, cholesterol esterase (CEase) and pancreatic lipase (PL) inhibitory activities of amaranth protein hydrolysates (APHs) were studied. Bromelain, chymotrypsin, and actinase E were used for generating APHs at 2, 4 & 6 h of hydrolysis. Higher PL inhibiting potential were observed in bromelain-derived APHs (IC50 = 0.38–0.66 mg/mL) in comparison to intact amaranth proteins (IC50 = 3.93 mg/mL). Bromelain-4 h hydrolysates (AB4) demonstrated significant inhibitory potential for both CEase (IC50 = 0.47 mg/mL) and PL (IC50 = 0.48 mg/mL) activity. Peptide identification in AB-4 hydrolysate revealed that among 17 bioactive peptides, three peptides (FPFPPTLGY, FGAPR, and FPFVPAPT) were predicted as potential PL inhibitors and only one peptide (FPFVPAPT) was predicted as CEase inhibitor based on the number of substrate binding sites on active site of the enzymes. This is the first study providing insights into amaranth protein derived bioactive peptide possessing CEase and LIP inhibitory potential. |
format |
article |
author |
Feyisola Fisayo Ajayi Priti Mudgil Chee-Yuen Gan Sajid Maqsood |
author_facet |
Feyisola Fisayo Ajayi Priti Mudgil Chee-Yuen Gan Sajid Maqsood |
author_sort |
Feyisola Fisayo Ajayi |
title |
Identification and characterization of cholesterol esterase and lipase inhibitory peptides from amaranth protein hydrolysates |
title_short |
Identification and characterization of cholesterol esterase and lipase inhibitory peptides from amaranth protein hydrolysates |
title_full |
Identification and characterization of cholesterol esterase and lipase inhibitory peptides from amaranth protein hydrolysates |
title_fullStr |
Identification and characterization of cholesterol esterase and lipase inhibitory peptides from amaranth protein hydrolysates |
title_full_unstemmed |
Identification and characterization of cholesterol esterase and lipase inhibitory peptides from amaranth protein hydrolysates |
title_sort |
identification and characterization of cholesterol esterase and lipase inhibitory peptides from amaranth protein hydrolysates |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/e41ee6f5000b4ef8acc32306231a590f |
work_keys_str_mv |
AT feyisolafisayoajayi identificationandcharacterizationofcholesterolesteraseandlipaseinhibitorypeptidesfromamaranthproteinhydrolysates AT pritimudgil identificationandcharacterizationofcholesterolesteraseandlipaseinhibitorypeptidesfromamaranthproteinhydrolysates AT cheeyuengan identificationandcharacterizationofcholesterolesteraseandlipaseinhibitorypeptidesfromamaranthproteinhydrolysates AT sajidmaqsood identificationandcharacterizationofcholesterolesteraseandlipaseinhibitorypeptidesfromamaranthproteinhydrolysates |
_version_ |
1718408291300671488 |